共 375 条
[1]
Moreno MG(2021)Liver cancer: therapeutic challenges and the importance of experimental models Can J Gastroenterol Hepatol 2 31-41
[2]
Gomez JA(2010)Hepatocellular carcinoma in the world and the Middle East Middle East J Dig Dis 28 753-770
[3]
Landeros SL(2014)Hepatocellular carcinoma epidemiology Best Pract Res Clin Gastroenterol 32 5-14
[4]
Santos A(2020)Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview J Egypt Natl Canc Inst 286 9-760
[5]
Ramirez HC(2009)Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection Cancer Lett 2 751-32689
[6]
Borunda JA(2007)Nanocarriers as an emerging platform for cancer therapy Nat Nanotechnol 4 32673-543
[7]
Poustchi H(2014)Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery RSC Adv 4 533-656
[8]
Sepanlou S(1993)DNA topoisomerase I and II as targets for rational design of new anticancer drugs Ann Oncol 45 649-2895
[9]
Esmaili S(1994)Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells Mol Pharmacol 36 2891-170
[10]
Mehrabi N(1976)Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells Cancer Res 65 157-3486